- Home
- XRTX vs ONFO Comparison
XRTX vs ONFO Comparison
Compare XRTX & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- ONFO
- Stock Information
- Founded
- XRTX 2011
- ONFO 2018
- Country
- XRTX Canada
- ONFO United States
- Employees
- XRTX N/A
- ONFO N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- ONFO Computer Software: Programming Data Processing
- Sector
- XRTX Health Care
- ONFO Technology
- Exchange
- XRTX Nasdaq
- ONFO Nasdaq
- Market Cap
- XRTX 4.4M
- ONFO 5.0M
- IPO Year
- XRTX N/A
- ONFO 2022
- Fundamental
- Price
- XRTX $0.62
- ONFO $0.79
- Analyst Decision
- XRTX
- ONFO
- Analyst Count
- XRTX 0
- ONFO 0
- Target Price
- XRTX N/A
- ONFO N/A
- AVG Volume (30 Days)
- XRTX 154.7K
- ONFO 1.6M
- Earning Date
- XRTX 11-17-2025
- ONFO 11-17-2025
- Dividend Yield
- XRTX N/A
- ONFO N/A
- EPS Growth
- XRTX N/A
- ONFO N/A
- EPS
- XRTX N/A
- ONFO N/A
- Revenue
- XRTX N/A
- ONFO $11,238,989.00
- Revenue This Year
- XRTX N/A
- ONFO N/A
- Revenue Next Year
- XRTX N/A
- ONFO N/A
- P/E Ratio
- XRTX N/A
- ONFO N/A
- Revenue Growth
- XRTX N/A
- ONFO 70.54
- 52 Week Low
- XRTX $0.52
- ONFO $0.60
- 52 Week High
- XRTX $1.79
- ONFO $1.95
- Technical
- Relative Strength Index (RSI)
- XRTX 47.57
- ONFO 39.60
- Support Level
- XRTX $0.52
- ONFO $0.60
- Resistance Level
- XRTX $0.61
- ONFO $0.81
- Average True Range (ATR)
- XRTX 0.05
- ONFO 0.11
- MACD
- XRTX 0.01
- ONFO -0.03
- Stochastic Oscillator
- XRTX 84.08
- ONFO 35.34
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.